vTv Therapeutics regains Nasdaq minimum bid compliance after reverse stock split

vTv Therapeutics Inc.

Nasdaq notified vTv on Dec 11, 2023 that it regained $1.00 minimum bid price compliance.
Company had received deficiency letter on Dec 22, 2022; extended deadline to Dec 18, 2023.
Effected a reverse stock split on Nov 20, 2023 to meet the bid price requirement.
Listing of common stock on Nasdaq Capital Market will continue.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.